Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending March 22, 2007. The report details a specific corporate action regarding the repurchase of the company's own shares in accordance with shareholder authority granted at the Annual General Meeting on May 17, 2006.
Key Financial Metrics
The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity. The only financial metric disclosed is the share repurchase price of 1,409.97 pence per share.
Material Changes
On March 22, 2007, the Company purchased 1,000,000 Ordinary shares of 25 pence each. Following this transaction, the total number of shares held in Treasury increased to 266,582,678. The number of shares in issue, excluding Treasury shares, stands at 5,743,327,066.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or discussion of risks and contingencies. It explicitly states that the announcement does not constitute an offer or solicitation to purchase securities.
Investor Verification Points
- Verify the total Treasury share count of 266,582,678 against subsequent filings.
- Confirm the total voting rights denominator of 5,743,327,066 shares for disclosure threshold calculations.
- Note that this filing is a notification of a share buyback and does not contain operational or financial performance results.